Febuxostat
- Product NDC
- 0904-7485
- Requested package NDC
- 0904-7485-03
- 11-digit product format
- 009047485
- Labeler code
- 0904
- Product ID
- 0904-7485_2bc97ac5-e672-4bb9-b0c4-596bbe935292
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Febuxostat
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA210461
- Marketing category
- ANDA
- Marketing start
- 2024-05-22
- Marketing end
- 2026-08-31
- Substance
- FEBUXOSTAT
- Active strength
- 80 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210461-001 | FEBUXOSTAT | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | |
| A210461-002 | FEBUXOSTAT | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210461-001 | AB |
| A210461-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A210461-001 | FEBUXOSTAT | 40MG | TABLET / ORAL | AB | 2019-12-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A210461-002 | FEBUXOSTAT | 80MG | TABLET / ORAL | AB | 2019-12-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A210461-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A210461-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Febuxostat | FEBUXOSTAT | Novadoz Pharmaceuticals LLC | d1969ea8-5178-42ee-97fc-feee8595e677 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
| Febuxostat | FEBUXOSTAT | Major Pharmaceuticals | 164feabd-f722-445b-b81a-d975b3db5f53 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 0904-7485-03 0904-7485 00904748503 |
| Febuxostat | FEBUXOSTAT | NuCare Pharmaceuticals,Inc. | a745be75-4fa5-cbf9-e053-2995a90a3a81 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
| Febuxostat | FEBUXOSTAT | MAJOR PHARMACEUTICALS | 13a80059-46f7-4453-ab37-72744657a08a | 2024-06-04 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
| Febuxostat | FEBUXOSTAT | Aphena Pharma Solutions - Tennessee, LLC | bf4d29c8-4731-42bc-887a-d8302add9ca9 | 2020-04-22 | Boxed warning, Warnings, Adverse reactions | 210461 ANDA210461 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Febuxostat
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FEBUXOSTAT | 80 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 101V0R1N2E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 164feabd-f722-445b-b81a-d975b3db5f53 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 253cf2a8-e060-f2e5-7334-8565436b95e4 | Product name | 6 | 20240213 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 351abe41-466c-4dd8-840a-0fdb68318bd5 | Product name | 1 | 20230316 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7485-03 | Febuxostat | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7485-03 | EA - Each | 0904-7485 | d59daed1-5488-49e2-8209-9df743a84799 | 1 | 2024-07-12 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 834235 | febuxostat 40 MG Oral Tablet | PSN | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
| 834241 | febuxostat 80 MG Oral Tablet | PSN | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
| 834235 | febuxostat 40 MG Oral Tablet | SCD | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
| 834241 | febuxostat 80 MG Oral Tablet | SCD | 164feabd-f722-445b-b81a-d975b3db5f53 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0904-7485-03 | 00904748503 | 30 TABLET, FILM COATED in 1 BOTTLE (0904-7485-03) | 2024-05-22 | 2026-08-31 | No | No | Historical |